Theragenics audit finds no grounds for execs' allegations
This article was originally published in Clinica
Executive Summary
A disagreement between Theragenics and its chief financial officer James MacLennan and general counsel and secretary Tracy Caswell over the actions of the CEO has led to the resignation of the Mr MacLennan and Ms Caswell. Bruce Smith, currently executive vice-president for strategy and business development, has been appointed as acting CFO.